Colorectal Cancer Clinical Trials in Salt Lake City

Showing 101-120 of 272 trials

A Study to Investigate LYL845 in Adults With Solid Tumors

NCT05573035

This is an open-label, multi-center, dose-escalation study with expansion cohorts, designed to evaluate the safety and anti-tumor activity of LYL845, an epigenetically reprogrammed tumor infiltrating lymphocyte (TIL) therapy, in participants with relapsed or refractory (R/R) metastatic or locally advanced melanoma, non-small cell lung cancer (NSCLC), and colorectal cancer (CRC).

MelanomaNon-small Cell Lung CancerColorectal Cancer

Lyell Immunopharma, Inc.39 participantsStarted Dec 2022

Sacramento, California, United States • Santa Monica, California, United States • Stanford, California, United States +15 more locations

RECRUITING< 1 mile

ColoCare Study - Colorectal Cancer Cohort

NCT02328677

ColoCare is an international prospective cohort study of stage I-IV colorectal cancer patients (ICD-10 C18-C20).

Colorectal Cancer

University of Utah5,000 participantsStarted Mar 2007

Los Angeles, California, United States • Tampa, Florida, United States • St Louis, Missouri, United States +4 more locations

A Study to Investigate LYL845 in Adults With Solid Tumors

ColoCare Study - Colorectal Cancer Cohort

Colorectal Cancer Trials in Other Cities

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies

Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer

A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors

Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Predicting Local and Distant Recurrence in T1 Colorectal Cancer

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

Stage II/III Colorectal Cancer Recurrence

Phase 2 Study of DKN-01 in Colorectal Cancer

Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC

Study of NKTR 255 in Combination With Cetuximab in Solid Tumors

A Phase 1b Study of WU-NK-101 in Combination With Cetuximab

MGD019 DART® Protein in Unresectable/Metastatic Cancer

Other Conditions in Salt Lake City